Sanofi India Limited
Sanofi India Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: SANOFI and BSE: 500674 (ISIN INE058A01010).
It has a market capitalisation of ₹6,625 crore, a last close of ₹2,880 on 2026-10-19, a one-year return of -38.4%.
Valuation: a price-to-earnings ratio of 20.46x, a price-to-book ratio of 8.84x, a dividend yield of 4.3%.
Profitability: return on equity of 40.6%, return on capital employed of 53.9%, an operating margin of 26.7%.
Growth: sales growth of -12.8% a year over three years, net profit growth of -19.3% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x, promoter holding of 60.4%.
| Metric | Value |
|---|---|
| Market capitalisation | 6,625 |
| Last close | ₹2,880 |
| P/E (TTM) | 20.46x |
| P/B | 8.84x |
| Dividend yield | 4.3% |
| ROE (FY) | 40.6% |
| ROCE (FY) | 53.9% |
| Operating margin (TTM) | 26.7% |
| Sales growth, 3-year CAGR | -12.8% |
| Profit growth, 3-year CAGR | -19.3% |
| Debt / equity | 0.00x |
| Promoter holding | 60.4% |
| 1-year return | -38.4% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means